We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
-0.3%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$752M
AUM Growth
+$253M
(+51%)
Cap. Flow
+$268M
Cap. Flow
% of AUM
35.64%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,082
New
405
Increased
619
Reduced
41
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$17.4M |
| 2 |
Apple
AAPL
|
+$7.52M |
| 3 |
Broadcom
AVGO
|
+$6.81M |
| 4 |
Bausch Health
BHC
|
+$5.93M |
| 5 |
NBIS
Nebius Group N.V.
NBIS
|
+$4.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$2.86M |
| 2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
+$1.98M |
| 3 |
EGLE
Eagle Bulk Shipping Inc.
EGLE
|
+$1.84M |
| 4 |
ALTR
Altera Corp
ALTR
|
+$1.74M |
| 5 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Healthcare | 13.08% |
| 3 | Industrials | 11.83% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Nike
NKE
$61.9B
| $6K | ﹤0.01% |
+102
| New | +$5.22K |
|
1002
Vornado Realty Trust
VNO
$7.38B
| $6K | ﹤0.01% |
+73
| New | +$6.05K |
|
1003
Vertex Pharmaceuticals
VRTX
$126B
| $6K | ﹤0.01% |
+50
| New | +$6.3K |
|
|
SRCL
1004
DELISTED
Stericycle Inc
SRCL
| $6K | ﹤0.01% |
+46
| New | +$6.3K |
|
|
GGP
1005
DELISTED
GGP Inc.
GGP
| $6K | ﹤0.01% |
+236
| New | +$6.58K |
|
1006
Adobe
ADBE
$105B
| $5K | ﹤0.01% |
+57
| New | +$4.45K |
|
1007
Capri Holdings
CPRI
$1.74B
| $5K | ﹤0.01% |
+109
| New | +$6.14K |
|
1008
Dollar Tree
DLTR
$25.2B
| $5K | ﹤0.01% |
+60
| New | +$4.74K |
|
1009
Equifax
EFX
$21.4B
| $5K | ﹤0.01% |
+54
| New | +$5.27K |
|
1010
Expeditors International
EXPD
$23.2B
| $5K | ﹤0.01% |
+112
| New | +$5.27K |
|
1011
Hershey
HSY
$36.6B
| $5K | ﹤0.01% |
+60
| New | +$5.66K |
|
1012
Intercontinental Exchange
ICE
$84.4B
| $5K | ﹤0.01% |
+105
| New | +$4.87K |
|
1013
Paychex
PAYX
$42.7B
| $5K | ﹤0.01% |
+104
| New | +$5.08K |
|
1014
Prologis
PLD
$133B
| $5K | ﹤0.01% |
+127
| New | +$5.17K |
|
1015
Public Storage
PSA
$61.3B
| $5K | ﹤0.01% |
+27
| New | +$5.18K |
|
1016
Regeneron Pharmaceuticals
REGN
$80.8B
| $5K | ﹤0.01% |
+10
| New | +$4.88K |
|
1017
Range Resources
RRC
$8.95B
| $5K | ﹤0.01% |
+98
| New | +$5.59K |
|
1018
American Tower
AMT
$80.4B
| $4K | ﹤0.01% |
+48
| New | +$4.54K |
|
1019
Brown-Forman Class B
BF.B
$13.1B
| $4K | ﹤0.01% |
+134
| New | +$4.07K |
|
1020
Ecolab
ECL
$79.9B
| $4K | ﹤0.01% |
+38
| New | +$4.37K |
|
1021
Fastenal
FAST
$59.5B
| $4K | ﹤0.01% |
+336
| New | +$3.54K |
|
1022
International Flavors & Fragrances
IFF
$21.9B
| $4K | ﹤0.01% |
+35
| New | +$4.04K |
|
1023
Moody's
MCO
$82.7B
| $4K | ﹤0.01% |
+39
| New | +$4.2K |
|
1024
O'Reilly Automotive
ORLY
$76.3B
| $4K | ﹤0.01% |
+255
| New | +$3.78K |
|
1025
Sherwin-Williams
SHW
$89.8B
| $4K | ﹤0.01% |
+42
| New | +$3.98K |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q2 2015 Portfolio in Review
As of Q2 2015, Vident Investment Advisory held 1,082 positions worth $752M, up 51% from $498M the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Vident Investment Advisory deployed $268M of net new capital in Q2 2015, opening 405 new positions and adding to 619 existing holdings. Its largest new stake was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $2.86M trimmed.
- Vident Investment Advisory's largest Q2 2015 buy was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
- Vident Investment Advisory added most to Apple in Q2 2015, an estimated $7.52M increase.
- Vident Investment Advisory's biggest Q2 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $2.86M.
- Vident Investment Advisory fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $1.98M.
- Vident Investment Advisory's ten largest holdings make up 9.6% of its $752M portfolio in Q2 2015.
- Vident Investment Advisory opened 405 new positions and closed 17 in Q2 2015.
- Vident Investment Advisory's portfolio value rose 51% quarter-over-quarter to $752M.
Based on Vident Investment Advisory's 13F filing for Q2 2015, filed 29 Jul 2015.